Skip Navigation

Visiting Dana-Farber? See our prescreening and mask requirements.

Kira Bona, MD, MPH

Pediatric Hematology/Oncology

No Ratings Available - Why Not? Make an Appointment

Kira Bona, MD, MPH


  • Physician
  • Assistant Professor of Pediatrics, Harvard Medical School

Clinical Interests

  • Hematologic malignancies

Contact Information

  • Appointments888-733-4662 (New Pediatric Patients)
    617-632-3270 (Established Pediatric Patients)
  • Fax617-632-4410


Dr. Kira Bona received her MD from the Yale University School of Medicine and her MPH from the Harvard T.H. Chan School of Public Health with a focus on clinical effectiveness. She completed her pediatrics residency in the Boston Combined Residency Program (BCRP) at Boston Children's Hospital and Boston Medical Center and her pediatric hematology/oncology subspecialty fellowship training at Dana-Farber Cancer Institute/Boston Children's Hospital. She joined the faculty at Dana-Farber/Boston Children's as a pediatric oncologist in 2012. In addition to her role in the treatment of children with leukemia and lymphoma, Dr. Bona is a physician-scientist with research focused on identifying poverty-associated outcome disparities in childhood cancer and developing interventions to ameliorate these disparities. Dr. Bona has been the recipient of several past awards and honors including a Young Investigator Award from the American Society of Clinical Oncology, a St. Baldrick's Fellow Award, a Junior Faculty Career Development Award from the National Palliative Care Research Center, a Charles H. Hood Child Health Research Grant, and an NCI K07 Mentored Career Development Award.

Board Certification:

  • Pediatric Hematology/Oncology, 2012
  • Pediatrics, 2009


  • Boston Children's Hospital/Dana-Farber Cancer Institute, Pediatric Hematology/Oncology


  • Boston Combined Residency Program, Boston Children's Hospital/Boston Medical Center, Pediatrics

Medical School:

  • Yale University School of Medicine

Recent Awards:

  • Member, Society for Pediatric Research
  • Boston Combined Residency Program Faculty Teaching Honor Roll, 2017-2018, 2019-2020


The Bona Lab at Dana-Farber Cancer Institute studies disparities in childhood cancer with a focus on improving childhood cancer outcomes by systematically considering poverty as a risk factor in the clinical trial setting and a target for interventions. Dr. Bona's research to date has demonstrated that poverty is associated with higher rates of relapse, decreased overall survival, and inferior symptom management even when children are treated on clinical trials. Her ongoing research includes open protocols to (1) identify mechanisms linking poverty and inferior outcomes by embedding survey and healthcare utilization research in multi-center clinical trials run by the DFCI/ALL Consortium and Children's Oncology Group; (2) develop and test novel poverty-targeted interventions; and (3) collaboratively investigate physiologic stress-responses that may induce chemotherapy resistance or immune dysfunction.

Neuner JM, Hamel MB, Phillips RS, Bona K, Aronson MD. Diagnosis and management of adults with pharyngitis. A cost-effectiveness analysis. Ann Intern Med. 2003;139(2):113-22.

Dussel V, Bona K, Heath JA, Hilden JM, Weeks JC, Wolfe J. Unmeasured costs of a child’s death: Perceived financial burden, work disruptions, and economic coping strategies used by American and Australian families who lost children to cancer. Journal of Clinical Oncology. 2011;(8):1007-13.

Bona K, Bates J, Wolfe J. Massachusetts' Pediatric Palliative Care Network: Successful implementation of a novel state-funded pediatric palliative care program. Journal of Palliative Medicine. 2011;14(11):1217-23.

Bona K, Dussel V, Orellana L, Kang T, Geyer R, Feudtner C, Wolfe J. Economic Impact of Advanced Pediatric Cancer on Families. Journal of Pain and Symptom Management, July 2013 epub ahead of print.


Dana-Farber Cancer Institute
450 Brookline Avenue
Boston, MA 02215
Get Directions